Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and Safety after conversion to
RaparoBell® or Myrept® in patients who in renal transplant patients undergoing maintenance
therapy with Mycophenolic acid.